slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 27,031-27,060
Pages 1,935
Rows per page 30
Slide function
27,031-27,060 of 58,039
30
Includes footnotes regarding non-GAAP measures and definitions.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
38
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines for Bausch & Lomb and SALIX, partially offset by other units.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
LOE stands for Loss of Exclusivity. The table shows the financial impact of products losing patent protection.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
Bausch Health Companies | Results Presentation Deck | 86 slidesBausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
The table compares inventory levels across two distinct periods (2019-2020 and 2020-2021).Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
Includes both GAAP and non-GAAP measures; highlights organic and reported revenue growth.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
Includes a callout for new disclosure regarding GAAP measures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
44
Includes non-GAAP reconciliations and segment-specific performance indicators.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
45
Includes both GAAP and non-GAAP measures with variance analysis.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
46
Includes a specific callout for a 16% revenue increase in specific products.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
47
Includes specific disclosures regarding non-GAAP measures and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
48
Includes both GAAP and non-GAAP measures with footnotes regarding constant currency and organic growth definitions.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
49
The slide includes a callout box for new GAAP disclosure measures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
50
Includes non-GAAP disclosures and organic growth metrics.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
51
Includes specific segment revenue, gross profit, operating expenses, and profit margins with year-over-year variance analysis.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
52
The slide appears to be a template or a placeholder for financial data, as the table body is obscured or empty.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
53
The table includes footnotes regarding non-GAAP measures and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
54
The table highlights key product revenue trends for FY21, 4Q21, 3Q21, 2Q21, 1Q21, FY20, and 4Q20.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
55
The table provides a detailed breakdown of revenue in millions for each product, allowing for year-over-year and quarter-over-quarter comparison.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
56
The table provides a comparative view of product revenue, highlighting Xifaxan as the primary revenue driver.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
57
The table includes 8 columns of financial data for 10 products, totaling 80 distinct data points.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
58
The table highlights FY21 and FY20 columns with a blue background for emphasis.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
59
The table tracks revenue in millions for 10 specific products across 7 time periods.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
60
Includes both GAAP and non-GAAP measures; explicitly notes exclusion of corporate G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
61
Includes both GAAP and non-GAAP measures; explicitly notes exclusion of corporate G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
62
Includes both GAAP and non-GAAP measures with footnotes regarding reconciliation.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
63
Includes both GAAP and non-GAAP financial measures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
64
Includes a callout box regarding new disclosure of GAAP measures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
65
Includes both GAAP and non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
67
The slide provides a detailed breakdown of adjustments to net income and their corresponding EPS impact.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit